PALFINGER MARINE secures a major contract with the Finnish Meyer Turku shipyard to provide lifesaving appliances (LSA) for Royal Caribbean International’s fourth Icon Class ship, set to debut in 2027.
French biotech Valneva has secured marketing approval in the UK for its chikungunya vaccine, Ixchiq (chikungunya vaccine), ...
The vaccine is manufactured at Valneva’s leading vaccine production site in Livingston, Scotland. The approval is based on IXCHIQ ® ’s final pivotal Phase 3 data, published in The Lancet, which ...
The approval is based on IXCHIQ ® 's final pivotal Phase 3 data, published in The Lancet , which included more than 4,000 participants and demonstrated that a single dose of the live-attenuated ...
The approval is based on IXCHIQ®â€™s final pivotal Phase 3 data ... We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and ...
Valneva has received Medicines and Healthcare products Regulatory Agency (MHRA) authorisation in the UK for the world’s first - and only - Chikungunya vaccine, IXCHIQ. The single-dose vaccine is ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 4 February 2025, approved the vaccine chikungunya vaccine (live) (brand name IXCHIQ) to protect adults against chikungunya ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results